Laurus Labs shares went up today on the bourses after the company release said that it has received two observations from U.S. Food and Drug Administration for its FDF & API Integrated Facility, Unit 2 at Visakhapatnam.
Further, the company also said that these observations are procedural in nature.
The stock gained nearly 1 per cent or Rs 3.60 to Rs 369.50 on the BSE.